Improving cancer prevention through HPV and HBV vaccination in Nigeria
US-Nigerian Cancer Control Center for Research on Implementation Science and Equity (C3-RISE)
This study is working to help more people in Nigeria get vaccinated against HPV and HBV to prevent cancer, using friendly community approaches to make the vaccines easier to access and understand.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10931740 on NIH RePORTER |
What this research studies
This research focuses on increasing the uptake of HPV and HBV vaccines in Nigeria to prevent cancer deaths. It employs innovative implementation science strategies, including community engagement and participatory methods, to ensure that these vaccines are accessible and widely accepted. The project aims to build local capacity and understanding of how to effectively implement and sustain cancer prevention interventions. By collaborating with various institutions, the research seeks to create a model that can be replicated in similar contexts.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals in Nigeria who are eligible for HPV and HBV vaccinations, particularly young people and those at risk of cervical and liver cancers.
Not a fit: Patients outside of Nigeria or those who are not eligible for HPV or HBV vaccinations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce preventable cancer deaths in Nigeria through increased vaccination rates.
How similar studies have performed: Previous research has shown success in implementing vaccination programs in similar contexts, indicating that this approach has potential for positive outcomes.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Iwelunmor, Juliet — Washington University
- Study coordinator: Iwelunmor, Juliet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.